Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sin City Seeds is a Nevada-based biotechnology company specializing in the genetic development and stabilization of medicinal cannabis cultivars. The company is widely recognized for creating the flagship "Sin City Fire" strain, a hybrid cross of Fire OG and Blue Power designed for specific therapeutic applications in pain management and stress reduction. Their operations focus on advanced botanical breeding, phenotype selection, and the optimization of cannabinoid and terpene profiles to produce high-quality genetic stock for the medical cannabis industry. By bridging traditional agriculture with modern genetic research, Sin City Seeds provides stabilized seeds that address a variety of patient needs in the legal medicinal market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sin City Fire.